Medtech Companies Face Challenges And Choices When Going Public
In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.
You may also be interested in...
Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.
The partnership with the Princess Margaret Cancer Center will support two studies of liquid biopsy testing for lung cancer.
Abionic CEO Nicolas Durand explains how Abionic is filling unmet needs in diagnostics and the Swiss company’s plans for expansion.